Inhibition of macrophage nitric-oxide production and Ia-expression by docosahexaenoic acid, a constituent of fetal and neonatal serum

American Journal of Reproductive Immunology

Volumn 36, Issue 1, 1996, Pages 1-10

  Khair El Din, Tarik A ^b   Sicher, Stanley C ^b   Vazquez, Miguel A ^b   Christopher, Y L U ^b   Lu, Christopher Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Docosahexaenoic acid; Macrophage; Placenta

Indexed keywords

CD4 ANTIGEN; DOCOSAHEXAENOIC ACID; ENDOTOXIN; GAMMA INTERFERON; IA ANTIGEN; ICOSANOID; INDOMETACIN; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NITRIC OXIDE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FETUS CIRCULATION; INFECTION; MACROPHAGE; MACROPHAGE FUNCTION; METABOLISM; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE;

EID: 0029819558     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1996.tb00133.x     Document Type: Article

References (55)

1. Redline RW, Lu CY. Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest 1987; 79:1234-1241.
2. Redline RW, Lu CY. Specific defects in the anti-listerial immune response in discrete regions of the murine uterus and placenta account for susceptibility to infection. J Immunol 1988; 140:3947-3955.
3. Lu CY, Redline RW, Shea CM, Dustin LB, McKay DB. Pregnancy as a natural model of allograft tolerance: Interactions between adherent macrophages and trophoblast populations. Transplantation 1989; 48:848-855.
4. Lu CY, Redline RW, McKay DB, Dustin LB, Shea CM. 11, Regulation of macrophage functions in the murine placenta and decidua: Implications for tolerance of the fetal allograft. In Transplantation Reviews, Voume 3. Morris PJ, Tilney NL (eds). W.B. Saunders Company, Philadelphia, 1989, pp 195-214.
5. Delorme J, Benassayag C, Christeff N, Vallette G, Savu L, Nunez E. Age-dependent responses of the serum non-esterified fatty acids to adrenalectomy and ovariectomy in developing rats. Biochim Biophys Acta 1984; 792:6-10.
6. Neuringer M, Connor ME, Petten CV, Barstad L. Dietary Omega-3 fatty acid deficiency and visual loss in infant Rhesus monkeys. J Clin Invest 1984; 73:272-276.
7. Dustin LB, Soberman R, Shea CM, Lu CY. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function. J Immunol 1990; 144:4888-4897.
8. Salem NJ, Kim HY, Yergey JA. 15, Docosahexaenoic acid: membrane function and metabolism. In Health effects of polyunsaturated fatty acids in seafoods. Simopoulos AP, Kifer RR, Martin RE (eds). Academic Press, Orlando, FL, 1986, pp 263-318.
9. Khair-El-Din TA, Sicher SC, Vazquez MA, Wright WJ, Lu CY. Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma induced Ia-expression by murine macrophages in vitro. J Immunol 1995; 154:1296-1306.
10. Khair-El-Din TA, Sicher SC, Vazquez MA, Chung GW, Stallworth KL, Kitamura K, Miller RT, Lu CY. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med 1996; 183:1241-1246.
11. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915-918.
12. Simopoulos AP Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54:38-63.
13. Kelley VE, Ferretti A, Izui S, Strom TB. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites and suppresses lupus in MRL-1pr mice. J Immunol 1985; 134:1914-1919.
14. Prickett JD, Robinson DR, Steinberg AD. Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW mice. J Clin Invest 1981; 68:556-559.
15. CA, Gonnerman WA, Ullman MD, Hayes KC, Franzblau C, Cathcart ES. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med 1985; 162:1336-1349.
16. Kelley VE, Kirkman RL, Bastos M, Barren LV, Strom TB. Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine. Transplantation 1989; 48:98-102.
17. Van der Heide JJH, Bilo HJG, Donker JM, Wilmink JM, Tegzess AM. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993; 329:769-773.
18. Chen RF. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 1967; 242:173.
19. Nathan CF, Hibbs JBJ. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3:65-70.
20. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 1989; 169:1011-1020.
21. Lu CY, Lemay PA, Lombardi MJ. Inhibition of antigen-specific activation of an L3T4+ T cell line by cyclosporine with maintenance of macrophage-mediated antigen presentation. Transplantation 1988; 45:187-194.
22. Oi VT, Jones PP, Goding JW, Herzenberg LA. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. In Lymphocyte hybridomas. Melchers F, Potter M, Warner N (eds). Springer Verlag, New York, 1978, pp 115-237.
23. Parmelee DC, Evenson MA, Deutsch HF. The presence of fatty acids in human alpha-fetoprotein. J Biol Chem 1978; 253:2114-2119.
24. Hsia JC, Wong TT, Trimble CE, Deutsch HF. 15, An in vitro model of placental transfer of polyunsaturated fatty acids: The albumin-AFP exchange system. In Biological activities of Alphal-fetoprotein: Volume 1. Mizejewski GJ, Jacobson HI, (eds). CRC Press, Boca Raton, FL, 1987, pp 205-212.
25. Crandall BF. Alpha-fetoprotein: A review. CRC Rev Clin Lab Sci 1981; 15:127-185.
26. Savu L, Benassayag C, Valletta G, Christeff N, Nunez E. Mouse alpha-1-fetoprotein and albumin: A comparison of their binding properties with estrogen and fatty acid ligands. J Biol Chem 1981; 256:9414-9418.
27. Lu CY, Changelian PS, Unanue ER. Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J Immunol 1984; 132:1722-1727.
28. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 1983; 80:3581-3584.
29. Taffet SM, Russell SW. Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol 1981; 126:424-427.
30. Tripp CS, Wyche A, Unanue ER, Needleman P. The functional significance of the regulation of macrophage Ia expression by endogeneous arachidonate metabolites in vitro. J Immunol 1986; 137:3915-3920.
31. Robert A, Schultz JR, Nezamis JE, Lancaster, R. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16,16-dimethyl PGE2. Gastroenterology 1976; 70:359-370.
32. Aiken JW, Shebuski RJ. Comparison in anesthetized dogs of the anti-aggegatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2. Prostaglandins 1980; 19:629-643.
33. Lefer AM, Smith EFI, Araki H, Smith JB, Aharony DD, Claremon DA, Magolda RL, Nicolaou KC. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci USA 1980; 77:1706-1710.
34. Lee TH, Austin KF. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. Adv Immunol 1986; 39:145-176.
35. Egan RW, Gale PH. 57, Comparative biochemistry of lipoxygenase inhibitors. In Prostaglandins, leukotrienes, and lipoxins: Biochemistry, mechanisms of action, and clinical applications. Bailey JM (eds). Plenum Press, New York, 1985, pp 593-607.
36. Falkenhein SF, MacKonald H, Huber MM, Koch D, Parker CW. Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway. J Immunol 1980; 125:163.
37. Wang W, Chadee K. Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo. Immunol 1992; 76:242-250.
38. Rouzer CA, Scott WA, Hamill AL, Cohn ZA. Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J Exp Med 1982; 155:733.
39. Tripp CS, Mahoney M, Needleman P. Calcium ionophore enables soluble agonists to stimulate macrophage 5-lipoxygenase. J Biol Chem 1985; 260:5895-5898.
40. Meslier N, Aldrich AJ, Bigby TD. Effect of interferon-gamma on the 5-lipoxygenase pathway of rat lung macrophages. Am J Respir Cell Mol Biol 1992; 6:93-99.
41. Scott WA, Pawlowski NA, Andreach M, Cohn ZA. Resting macrophages produce distinct metabolites from exogenous arachidonic acid. J Exp Med 1982; 155:535-547.
42. Kooler M, Schonfeld W, Knoller J, Bremm KD, Konig W, Spur B, Crea A, Peters W. The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta 1985; 833:128-134.
43. Sperling RI, Robin JL, Kylander KA, Lee TH, Lewis RA, Austen KF. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. J Immunol 1987; 139:4186-4191.
44. Tessner TG, O'Flaherty JT, Wykle RL. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem 1989; 264:4794-4799.
45. Lokesh BR, German B, Kinsella JE. Differential effects of docosahexaenoic acid and eicosanpentaenoic acid on suppression of lipoxygenase pathway in peritoneal macrophages. Biochim Biophys Acta 1988; 99:107.
46. Chapkin RS, Somers SD, Erickson KL. Dietary manipulation of macrophage phospholipid classes: Selective increase of dihomogammalinolenic acid. Lipids 1988; 23:766.
47. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607-614.
48. Olson M, Lindahl G, Ruoslahti E. Genetic control of alpha-fetoprotein synthesis in the mouse. J Exp Med 1977; 145:819.
49. Briskin MJ, McEvoy LM, Butcher EC. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993; 363:461-464.
50. Von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985; 76:2446-2450.
51. Pawlowski NA, Scott WA, Andreach M, Cohn ZA. Uptake and metabolism of monohydroxy-eicosatetraenoic acids by macrophages. J Exp Med 1982; 155:1653-1664.
52. Levy BD, Romano M, Champman HA, Reilly JJ, Drazen J, Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 1994; 92:1572-1579.
53. Ramesha CS, Pickett WC. Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J Biol Chem 1986; 261:7592-7595.
54. Chapkin RS, Somers SD, Schumacher L, Erickson KL. Fatty acid composition of macrophage phospholipids in mice fed fish or borage oil. Lipids 1988; 23:380.
55. Hardardottir I, Kinsella JE. Increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio increases tumor necrosis factor production by murine resident peritoenal macrophages without an effect on elicited peritoneal macrophages. J Nutr 1992; 1942:1951.